OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Triple negative breast cancer: Pitfalls and progress
Paola Zagami, Lisa A. Carey
npj Breast Cancer (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 286
Paola Zagami, Lisa A. Carey
npj Breast Cancer (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 286
Showing 1-25 of 286 citing articles:
In situ forming pH/ROS-responsive niche-like hydrogel for ultrasound-mediated multiple therapy in synergy with potentiating anti-tumor immunity
Zideng Dai, Qiuhong Zhang, Xiaohong Li, et al.
Materials Today (2023) Vol. 65, pp. 62-77
Closed Access | Times Cited: 40
Zideng Dai, Qiuhong Zhang, Xiaohong Li, et al.
Materials Today (2023) Vol. 65, pp. 62-77
Closed Access | Times Cited: 40
Triple-negative breast cancer: epidemiology, molecular mechanisms, and modern vaccine-based treatment strategies
Asad Mustafa Karim, Jeong Eun Kwon, Tanveer Ali, et al.
Biochemical Pharmacology (2023) Vol. 212, pp. 115545-115545
Closed Access | Times Cited: 38
Asad Mustafa Karim, Jeong Eun Kwon, Tanveer Ali, et al.
Biochemical Pharmacology (2023) Vol. 212, pp. 115545-115545
Closed Access | Times Cited: 38
Recent advancements in nanoconstructs for the theranostics applications for triple negative breast cancer
Ashutosh Gupta, Kumar Nishchaya, Moumita Saha, et al.
Journal of Drug Delivery Science and Technology (2024) Vol. 93, pp. 105401-105401
Open Access | Times Cited: 14
Ashutosh Gupta, Kumar Nishchaya, Moumita Saha, et al.
Journal of Drug Delivery Science and Technology (2024) Vol. 93, pp. 105401-105401
Open Access | Times Cited: 14
“Triple-Punch” Strategy Exosome-Mimetic Nanovesicles for Triple Negative Breast Cancer Therapy
Chenhong Zhang, Shuangshuang Tang, Meilin Wang, et al.
ACS Nano (2024)
Closed Access | Times Cited: 12
Chenhong Zhang, Shuangshuang Tang, Meilin Wang, et al.
ACS Nano (2024)
Closed Access | Times Cited: 12
Co‐delivery CPT and PTX prodrug with a photo/thermo‐responsive nanoplatform for triple‐negative breast cancer therapy
Wenhui Zhou, Xiaodong Ma, Jie Wang, et al.
Smart Medicine (2022) Vol. 1, Iss. 1
Open Access | Times Cited: 60
Wenhui Zhou, Xiaodong Ma, Jie Wang, et al.
Smart Medicine (2022) Vol. 1, Iss. 1
Open Access | Times Cited: 60
Response-guided neoadjuvant sacituzumab govitecan for localized triple-negative breast cancer: results from the NeoSTAR trial
Laura M. Spring, Sara M. Tolaney, Geoffrey Fell, et al.
Annals of Oncology (2023) Vol. 35, Iss. 3, pp. 293-301
Open Access | Times Cited: 33
Laura M. Spring, Sara M. Tolaney, Geoffrey Fell, et al.
Annals of Oncology (2023) Vol. 35, Iss. 3, pp. 293-301
Open Access | Times Cited: 33
Targeting tumor–stromal interactions in triple-negative breast cancer using a human vascularized micro-tumor model
Stephanie J. Hachey, Christopher J. Hatch, Daniela Gaebler, et al.
Breast Cancer Research (2024) Vol. 26, Iss. 1
Open Access | Times Cited: 10
Stephanie J. Hachey, Christopher J. Hatch, Daniela Gaebler, et al.
Breast Cancer Research (2024) Vol. 26, Iss. 1
Open Access | Times Cited: 10
A second-generation eIF4A RNA helicase inhibitor exploits translational reprogramming as a vulnerability in triple-negative breast cancer
Regina Cencic, Young Kyuen Im, Sai Kiran Naineni, et al.
Proceedings of the National Academy of Sciences (2024) Vol. 121, Iss. 4
Open Access | Times Cited: 9
Regina Cencic, Young Kyuen Im, Sai Kiran Naineni, et al.
Proceedings of the National Academy of Sciences (2024) Vol. 121, Iss. 4
Open Access | Times Cited: 9
Advancements and challenges in triple-negative breast cancer: a comprehensive review of therapeutic and diagnostic strategies
Nating Xiong, Heming Wu, Zhikang Yu
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 8
Nating Xiong, Heming Wu, Zhikang Yu
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 8
Injectable Alginate Complex Hydrogel Loaded with Dual-Drug Nanovectors Offers Effective Photochemotherapy against Triple-Negative Breast Cancer
Yu‐Hsiang Lee, Chih‐Ting Lin
Biomacromolecules (2024) Vol. 25, Iss. 3, pp. 2041-2051
Open Access | Times Cited: 7
Yu‐Hsiang Lee, Chih‐Ting Lin
Biomacromolecules (2024) Vol. 25, Iss. 3, pp. 2041-2051
Open Access | Times Cited: 7
Natural Compounds and Breast Cancer: Chemo-Preventive and Therapeutic Capabilities of Chlorogenic Acid and Cinnamaldehyde
Yusuff Olayiwola, Lauren Gollahon
Pharmaceuticals (2024) Vol. 17, Iss. 3, pp. 361-361
Open Access | Times Cited: 7
Yusuff Olayiwola, Lauren Gollahon
Pharmaceuticals (2024) Vol. 17, Iss. 3, pp. 361-361
Open Access | Times Cited: 7
Paper-based screen-printed electrode to detect miRNA-652 associated to triple-negative breast cancer
Ada Raucci, Wanda Cimmino, Sara Pia Grosso, et al.
Electrochimica Acta (2024) Vol. 487, pp. 144205-144205
Open Access | Times Cited: 7
Ada Raucci, Wanda Cimmino, Sara Pia Grosso, et al.
Electrochimica Acta (2024) Vol. 487, pp. 144205-144205
Open Access | Times Cited: 7
Circulating tumour mutation detection in triple-negative breast cancer as an adjunct to tissue response assessment
Elena Zaikova, Brian Yu Chieh Cheng, Viviana Cerda, et al.
npj Breast Cancer (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 6
Elena Zaikova, Brian Yu Chieh Cheng, Viviana Cerda, et al.
npj Breast Cancer (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 6
Implications of tumor-infiltrating lymphocytes in early-stage triple-negative breast cancer: clinical oncologist perspectives
Mahira Lopes Rosa, Tomás Reinert, Maiane Maria Pauletto, et al.
Translational Breast Cancer Research (2024) Vol. 5, pp. 4-4
Open Access | Times Cited: 6
Mahira Lopes Rosa, Tomás Reinert, Maiane Maria Pauletto, et al.
Translational Breast Cancer Research (2024) Vol. 5, pp. 4-4
Open Access | Times Cited: 6
The Molecular Mechanisms behind Advanced Breast Cancer Metabolism: Warburg Effect, OXPHOS, and Calcium
Erna Mitaishvili, Hanna Feinsod, Zachary David, et al.
Frontiers in Bioscience-Landmark (2024) Vol. 29, Iss. 3
Open Access | Times Cited: 6
Erna Mitaishvili, Hanna Feinsod, Zachary David, et al.
Frontiers in Bioscience-Landmark (2024) Vol. 29, Iss. 3
Open Access | Times Cited: 6
Ziziphus mauritiana Leaf Extract Induces ROS-dependent Apoptosis by Downregulation of CD81 in MDA- MB 231 Triple Negative Breast Cancer Cells
Dian Lestari, Gondo Mastutik, Indri Safitri Mukono
Research Square (Research Square) (2025)
Closed Access
Dian Lestari, Gondo Mastutik, Indri Safitri Mukono
Research Square (Research Square) (2025)
Closed Access
Carbonic Anhydrase IX Enzyme in Triple Negative Breast Carcinoma: Relationship With Prognostic Factors and Response to Neoadjuvant Chemotherapy
Özgen Arslan Solmaz, Nizamettin Kutluer, Mehmet Buğra Bozan
Meme sağlığı dergisi/Meme sağlığı dergisi (2025) Vol. 21, Iss. 1, pp. 57-62
Open Access
Özgen Arslan Solmaz, Nizamettin Kutluer, Mehmet Buğra Bozan
Meme sağlığı dergisi/Meme sağlığı dergisi (2025) Vol. 21, Iss. 1, pp. 57-62
Open Access
The protective role of baicalin regulation of autophagy in cancers
Qí Zhāng, Shiyun Guo, Han Ge, et al.
Cytotechnology (2025) Vol. 77, Iss. 1
Closed Access
Qí Zhāng, Shiyun Guo, Han Ge, et al.
Cytotechnology (2025) Vol. 77, Iss. 1
Closed Access
Inhibition of Triple-Negative Breast Cancer by Pulsed Electric Fields of Five Nanosecond (5 ns PEFs)
Yancheng Wang, Kun Qian, Qifeng Yang, et al.
Lecture notes in electrical engineering (2025), pp. 675-686
Closed Access
Yancheng Wang, Kun Qian, Qifeng Yang, et al.
Lecture notes in electrical engineering (2025), pp. 675-686
Closed Access
Canine mammary tumors as a promising adjunct preclinical model for human breast cancer research: similarities, opportunities, and challenges
Zeeshan Ahmad Bhutta, Kyung‐Chul Choi
Archives of Pharmacal Research (2025)
Closed Access
Zeeshan Ahmad Bhutta, Kyung‐Chul Choi
Archives of Pharmacal Research (2025)
Closed Access
The role of the complement system in the response to cytotoxic therapy
K Lee, Qingyang Zhang, Tatsuya Suwa, et al.
Seminars in Immunology (2025) Vol. 77, pp. 101927-101927
Open Access
K Lee, Qingyang Zhang, Tatsuya Suwa, et al.
Seminars in Immunology (2025) Vol. 77, pp. 101927-101927
Open Access
High CXCL8 expression predicting poor prognosis in triple-negative breast cancer
Sumin Tang, Yuqing Zhang, Liying Song, et al.
Anti-Cancer Drugs (2025) Vol. 36, Iss. 3, pp. 246-252
Closed Access
Sumin Tang, Yuqing Zhang, Liying Song, et al.
Anti-Cancer Drugs (2025) Vol. 36, Iss. 3, pp. 246-252
Closed Access
Role of Epigallocatechin Gallate in Selected Malignant Neoplasms in Women
Anna Markowska, Michał Antoszczak, Janina Markowska, et al.
Nutrients (2025) Vol. 17, Iss. 2, pp. 212-212
Open Access
Anna Markowska, Michał Antoszczak, Janina Markowska, et al.
Nutrients (2025) Vol. 17, Iss. 2, pp. 212-212
Open Access
Design of a theranostic Gd (III)–Cu (I) complex to inhibit growth and metastasis of triple-negative breast cancer
Xueyu Man, Minghui Zhu, Shanhe Li, et al.
Rare Metals (2025)
Closed Access
Xueyu Man, Minghui Zhu, Shanhe Li, et al.
Rare Metals (2025)
Closed Access
CD-44 targeted nanoparticles for combination therapy in an in vitro model of triple-negative breast cancer: targeting the tumour inside out
Silvia Gómez-Pastor, Auréane Maugard, Harriet R. Walker, et al.
Colloids and Surfaces B Biointerfaces (2025) Vol. 249, pp. 114504-114504
Open Access
Silvia Gómez-Pastor, Auréane Maugard, Harriet R. Walker, et al.
Colloids and Surfaces B Biointerfaces (2025) Vol. 249, pp. 114504-114504
Open Access
